Similar Papers

Paper Title
Journal
Date
Author
Nanobodies in cell-mediated immunotherapy: On the road to fight cancer.
Amirhosein Maali ... Shafieeh Mansoori
Frontiers in Immunology | VOL. 14
Amirhosein Maali, et. al.Amirhosein Maali ... Shafieeh Mansoori
25 Jan 2023
Honokiol-mediated Inhibition of PI3K/mTOR Pathway
Courtney Crane ... Jack Arbiser
Journal of Immunotherapy | VOL. 32
Courtney Crane, et. al.Courtney Crane ... Jack Arbiser
01 Jul 2009
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response.
Laura Mosca ... Filomena De Nigris
Cancers | VOL. 14
Laura Mosca, et. al.Laura Mosca ... Filomena De Nigris
14 Jul 2022
Abstract 1372: BTN1A1 regulates T cell-mediated cancer immunotherapy by interacting with Galectin-9, PD-1, and TIM3
Seung Hoon Lee ... Andrew H Park
Cancer Research | VOL. 84
Seung Hoon Lee, et. al.Seung Hoon Lee ... Andrew H Park
22 Mar 2024
View more papers

More From: ACS Central Science

Paper Title
Journal
Date
Author
Is Europe Running out of Chemistry Teachers?
Vanessa Zainzinger
ACS Central Science | VOL. -
Vanessa ZainzingerVanessa Zainzinger
15 Jan 2025
Measuring the Elusive Half-Life of Samarium-146
Mara Johnson-Groh
ACS Central Science | VOL. -
Mara Johnson-GrohMara Johnson-Groh
13 Jan 2025
Strand-Swapped SH3 Domain Dimer with Superoxide Dismutase Activity
Florian R Häge ... Franziska Thomas
ACS Central Science | VOL. -
Florian R Häge, et. al.Florian R Häge ... Franziska Thomas
10 Jan 2025
Identification of a Privileged Scaffold for Inhibition of Sterol Transport Proteins through the Synthesis and Ring Distortion of Diverse, Pseudo-Natural Products
Frederik Simonsen Bro ... Luca Laraia
ACS Central Science | VOL. -
Frederik Simonsen Bro, et. al.Frederik Simonsen Bro ... Luca Laraia
08 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.